Ectopic ZEB1 expression induced chemoresistance to chemotherapeutics used in HCC treatment (Fig. 2d) and significantly increased motility of PLC/PRF/5 cells (Fig. 2e) in agreement with our in vivo observations that ZEB1 immunoexpression is associated with metastatic phenotype. Here, ZEB1 is linked to hepatocellular carcinoma.